Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
vigabatrin (sabril) (1 trial)
Cocaine-Related Disorders (Phase 2)
Trials (1 total)
Trial APIs (1 total)